ActivistsInvestorsTrumpPoliticiansSerenityCitriniBurrySemianalysisSwingTradeArbitrageSearch

$RXRX:NASDAQ · RECURSION PHARMACEUTICALS IN

Recursion — AI drug discovery

Sector: health

Conviction from: NASDAQ

52-week range: 2.775.24

3 tracked filer(s) hold this · 1 opened, 1 added, 1 trimmed in 30-SEP-2026

Aggregate 13FScore 64 — mean of 3 scored holder(s) · buyers (new/add) avg 65. Higher = the smart money in this name has the better track record.

Filer13FScoreThis quarterSharesValue% of their book
Steve Cohen / Point7275New buy238,435$984,7370.0%
Bridgewater55Added +156%96,596$398,9410.0%
Paul Tudor Jones / Tudor61Trimmed -17%358,600$1,481,0180.0%

Beyond 13F — activists, insiders, politicians & research

Citrini Research coverage report library →

ReportDateStance
#124 — State of the Themes: June 20262026-06-01WATCH

Every tracked holder of this name, sorted new → added → flat → trimmed. Shares = reported 13F share count; Value as reported (a few managers file values in $thousands). Generated 2026-11-17.